KRAS and metastatic colorectal cancer: Petrelli Petrelli F F Coinu Coinu A A Cabiddu Cabiddu M M Ghilardi Ghilardi M M Barni Barni S S KRAS as prognostic biomarker in metastatic colorectal cancer patients treated with bevacizumab: a pooled analysis of 12 published trials KRAS as prognostic biomarker in metastatic colorectal cancer patients treated with bevacizumab: a pooled analysis of 12 published trials Med.